TCL Archive AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm May 8, 2013
TCL Archive In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm January 23, 1998
TCL Archive Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say. July 29, 2005